Furosemide
- Product NDC
- 0054-3294
- Requested package NDC
- 0054-3294-50
- 11-digit product format
- 000543294
- Labeler code
- 0054
- Product ID
- 0054-3294_bc62ddda-7639-4090-99f0-7dd4d13518f3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA070434
- Marketing category
- ANDA
- Marketing start
- 1988-07-12
- Substance
- FUROSEMIDE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A070434-001 | FUROSEMIDE | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | AA | RS | 1987-04-22 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A070434-001 | FUROSEMIDE | 10MG/ML | SOLUTION / ORAL | RS | 1987-04-22 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A070434-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A070434-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A070434-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A070434-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A070434-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A070434-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A070434-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A070434-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A070434-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A070434-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A070434-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A070434-001 | AA | 1 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Furosemide
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FUROSEMIDE | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7LXU5N7ZO5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9e493331-dddd-496e-abf8-61747fb67aba | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d80d3aff-3a63-4d7b-a2be-fd9388b04330 | Product name | 9 | 20250806 |
| 9061e89f-9c86-4196-b34b-886fc1673cc4 | Product name | 1 | 20140821 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0054-3294-46 | Furosemide | 60 mL in 1 BOTTLE | SOLUTION | 60 | 18 | |
| 0054-3294-50 | Furosemide | 120 mL in 1 BOTTLE | SOLUTION | 120 | 18 | |
| 0054-3294-46 | Furosemide | 60 mL in 1 BOTTLE, DROPPER | SOLUTION | 60 | 1 | |
| 0054-3294-50 | Furosemide | 120 mL in 1 BOTTLE, DROPPER | SOLUTION | 120 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0054-3294-46 | ML - Milliliter | 0054-3294 | 5378252d-1e74-4c17-9381-0a014930a27e | 1 | 2012-07-24 |
| 0054-3294-50 | ML - Milliliter | 0054-3294 | d9acaccb-17a9-45b3-9add-41b1a0ab5595 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0054-3294 | FUROSEMIDE TABLET FUROSEMIDE SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 16 | Current NDC, Legacy NDC, 2 package rows | 20250511_9e493331-dddd-496e-abf8-61747fb67aba.zip |
| 0054-3294 | FUROSEMIDE (FUROSEMIDE) TABLET FUROSEMIDE (FUROSEMIDE) SOLUTION [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 1 | Current NDC, Legacy NDC, 2 package rows | 20070509_EA623E21-E9FD-4EF1-843B-82CBC05AF5BF.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Atlantic Biologicals Corp. | 54ed0dd9-2fa8-269a-e063-6294a90a607c | 2026-06-23 | Warnings, Adverse reactions | 070434 ANDA070434 |
| Furosemide | FUROSEMIDE | Hikma Pharmaceuticals USA Inc. | 9e493331-dddd-496e-abf8-61747fb67aba | 2025-11-03 | Warnings, Adverse reactions | 070434 ANDA070434 0054-3294-50 0054-3294 00054329450 |
| Furosemide | FUROSEMIDE | Precision Dose Inc. | 4a746634-379b-4847-a965-7607d2a71bed | 2022-09-21 | Warnings, Adverse reactions | 070434 ANDA070434 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0054-3294-50 | 00054329450 | 120 mL in 1 BOTTLE (0054-3294-50) | 120 ml | 1988-07-12 | 0000-00-00 | No | No | Current |